DirectorsTalk LSE Stock market news, financial, press release, articles and interviews
On 3 December, Non-Standard Finance (LON:NSF) held an investor day at the Reading branch of Everyday Loans (EL) and its head office in Bourne End. Investors and analysts thus got ...
Read Article »Home » Hardman Research
Hardman Research
-
REDX Pharma RXC006: first anti-fibrosis development candidate
-
Palace Capital Interim results to September 2018 reported
-
Redx Pharma Streamlined, focused and good value
-
The 600 Group Trading still healthy, with good order book
-
Titon Holdings Plc My aim is true
-
Haydale Graphene Industries Plc Enlightenment delayed
-
REDX Pharma ROCK2 inhibitors in chronic kidney disease
-
Alliance Pharma International brands driving performance
-
International Lithium Corp. Canada restructured, key announcements pending
-
Warpaint London Plc Trading update: softening UK market
-
ValiRx Plc VAL401 Phase II trial completed
-
Primary Health Properties Growing the footprint; optimising income and NAV
-
SatoshiPay An emerging leader in digital nanopayments
-
Morses Club Plc Sustainable growth from focus on quality
-
Palace Capital Initiation of coverage
-
Diurnal Group Unexpected Phase III trial outcome
-
Advanced Oncotherapy Four components integrated
-
City of London Investment Group Plc Solid FUM update offset by margin changes
-
UK Housebuilding Sector in 3Q 2018… …trains, cows and beyond
-
Warpaint London Plc 1H’18 interims: delivering the results
-
Burford Capital Equity issue ensures growth is not adjourned
-
Redx Pharma Back to the clinic
-
Oxford BioMedica Risk-sharing in cystic fibrosis gene-therapy
-
The 600 Group Trading healthy, pension buyout, dividend restored
-
International Lithium Corp. Partnered with China’s biggest lithium player
-
Arbuthnot Banking Group 1H’18 results: continuing the good work
-
Non Standard Finance 1H’18 preview: costs 1H-weighted, revenue 2H
-
Morses Club Quality Street
-
City of London Investment Group Dividend increase boosts yield
-
Allergy Therapeutics Steady performance in a tough market
-
REPORT: UK Housebuilding Sector 2Q 2018; and beyond (the World Cup)
-
Koovs plc The Future is here
-
Evgen Pharma 2018, a pivotal year
-
Genedrive plc Preventing hearing loss in newborns
-
Redx Pharma Plc “Focus, Realism and Results” – Ian Ross, Chairman
-
Warpaint London PLC Painting a bright future
-
Oxford BioMedica Gene-therapy for Parkinson’s: clinical progression
-
Koovs plc Successful fund raising
-
Evgen Pharma Encouraging interim data from the STEM trial
-
Chamberlin Plc Trading strong, technical issues largely resolved
